Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
latanoprost, Quantity: 50 microgram/mL; timolol maleate, Quantity: 6.83 mg/mL (Equivalent: timolol, Qty 5 mg/mL)
Arrotex Pharmaceuticals Pty Ltd
Latanoprost,Timolol maleate
Eye Drops, solution
Excipient Ingredients: dibasic sodium phosphate; monobasic sodium phosphate monohydrate; benzalkonium chloride; sodium chloride; water for injections; sodium hydroxide; hydrochloric acid
Ophthalmic
2.5 mL
(S4) Prescription Only Medicine
Reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. Latanoprost/Timolol eye drops should not be used to initiate therapy.
Visual Identification: clear and colourless aqueous solution; Container Type: Bottle; Container Material: LDPE; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius
Licence status A
2016-05-03